Skip to main content
Erschienen in: Pediatric Cardiology 5/2020

14.03.2020 | Original Article

Echocardiographic Parameters During and Beyond Onset of Kawasaki Disease Correlate with Onset Serum N-Terminal pro-Brain Natriuretic Peptide (NT-proBNP)

verfasst von: Laurent Desjardins, Audrey Dionne, Léamarie Meloche-Dumas, Anne Fournier, Nagib Dahdah

Erschienen in: Pediatric Cardiology | Ausgabe 5/2020

Einloggen, um Zugang zu erhalten

Abstract

The N-terminal proBNP (NT-proBNP), produced by cardiomyocytes, has several reported utilities and associations in acute Kawasaki disease (KD). The objective of this study is to examine the relationship between serum values of NT-proBNP at time of KD diagnosis with cardiac systolic, diastolic function and electrocardiographic changes, at onset of the disease and during the first year of follow-up. KD was diagnosed in 127 children between March 2007 and July 2014, mean diagnostic age 3.5 ± 2.9 years. Coronary artery maximum z score was 2.6 ± 2.8 (range − 0.6 to + 18.9), with giant aneurysm in 5/122 (4.1%). Age-adjusted NT-proBNP was 2.6 ± 1.6 z score, 78/122 (63.9%) > 2.0. There was a crescendo correlation between onset NT-proBNP z score and C-Reactive protein (CRP) serum levels (slope + 0.49, p < 0.001). There was a crescendo correlation between NT-proBNP z score and indexed left ventricular (LV) mass (slope + 1.86, p = 0.02), LV diastolic function parameter E/e′ ratio (slope + 0.31, p = 0.04) and a decrescendo correlation with age-adjusted LV shortening fraction (SF) (− 0.63, p = 0.02). Lower SF z score, higher left ventricular mass index and E/e′ ratio were associated with higher NT-proBNP z score, but without correlation with CRP levels. Within 2–3 months from the onset of the disease, there was a resolution of the systolic dysfunction. Electrocardiographic parameter changes were associated with decreased LV shortening fraction but not with NT-proBNP. KD patients with elevated NT-proBNP at onset have sub-clinical myocardial involvement and might benefit from follow-up and continued evaluation, even in the absence of coronary artery involvement.
Literatur
2.
Zurück zum Zitat Taubert KA, Rowley AH, Shulman ST (1991) Nationwide survey of Kawasaki disease and acute rheumatic fever. J Pediatr 119(2):279–282CrossRef Taubert KA, Rowley AH, Shulman ST (1991) Nationwide survey of Kawasaki disease and acute rheumatic fever. J Pediatr 119(2):279–282CrossRef
3.
Zurück zum Zitat McCrindle BW, Rowley AH, Newburger JW, Burns JC, Bolger AF, Gewitz M, Baker AL, Jackson MA, Takahashi M, Shah PB, Kobayashi T, Wu MH, Saji TT, Pahl E, American Heart Association Rheumatic Fever E, Kawasaki Disease Committee of the Council on Cardiovascular Disease in the Y, Council on C, Stroke N, Council on Cardiovascular S, Anesthesia, Council on E, Prevention (2017) Diagnosis, treatment, and long-term management of Kawasaki Disease: a scientific statement for health professionals from the American Heart Association. Circulation 135(17):e927–e999. https://doi.org/10.1161/CIR.0000000000000484 CrossRef McCrindle BW, Rowley AH, Newburger JW, Burns JC, Bolger AF, Gewitz M, Baker AL, Jackson MA, Takahashi M, Shah PB, Kobayashi T, Wu MH, Saji TT, Pahl E, American Heart Association Rheumatic Fever E, Kawasaki Disease Committee of the Council on Cardiovascular Disease in the Y, Council on C, Stroke N, Council on Cardiovascular S, Anesthesia, Council on E, Prevention (2017) Diagnosis, treatment, and long-term management of Kawasaki Disease: a scientific statement for health professionals from the American Heart Association. Circulation 135(17):e927–e999. https://​doi.​org/​10.​1161/​CIR.​0000000000000484​ CrossRef
5.
Zurück zum Zitat Shiraishi M, Fuse S, Mori T, Doyama A, Honjyo S, Hoshino Y, Hoshino E, Kawaguchi A, Kuroiwa Y, Hotsubo T (2013) N-terminal pro-brain natriuretic Peptide as a useful diagnostic marker of acute Kawasaki disease in children. Circ J 77(8):2097–2101CrossRef Shiraishi M, Fuse S, Mori T, Doyama A, Honjyo S, Hoshino Y, Hoshino E, Kawaguchi A, Kuroiwa Y, Hotsubo T (2013) N-terminal pro-brain natriuretic Peptide as a useful diagnostic marker of acute Kawasaki disease in children. Circ J 77(8):2097–2101CrossRef
8.
Zurück zum Zitat Burns JC, Shike H, Gordon JB, Malhotra A, Schoenwetter M, Kawasaki T (1996) Sequelae of Kawasaki disease in adolescents and young adults. J Am Coll Cardiol 28(1):253–257CrossRef Burns JC, Shike H, Gordon JB, Malhotra A, Schoenwetter M, Kawasaki T (1996) Sequelae of Kawasaki disease in adolescents and young adults. J Am Coll Cardiol 28(1):253–257CrossRef
9.
Zurück zum Zitat Amoozgar H, Ahmadipour M, Amirhakimi A (2013) QT dispersion and T wave peak-to-end interval dispersion in children with Kawasaki disease. Int Cardiovasc Res J 7(3):99–103PubMedPubMedCentral Amoozgar H, Ahmadipour M, Amirhakimi A (2013) QT dispersion and T wave peak-to-end interval dispersion in children with Kawasaki disease. Int Cardiovasc Res J 7(3):99–103PubMedPubMedCentral
12.
Zurück zum Zitat Brown H, Prescott R (2015) Applied mixed models in medicine Brown H, Prescott R (2015) Applied mixed models in medicine
13.
Zurück zum Zitat Fujiwara H, Hamashima Y (1978) Pathology of the heart in Kawasaki disease. Pediatrics 61(1):100–107PubMed Fujiwara H, Hamashima Y (1978) Pathology of the heart in Kawasaki disease. Pediatrics 61(1):100–107PubMed
14.
Zurück zum Zitat Yutani C, Okano K, Kamiya T, Oguchi K, Kozuka T, Ota M, Onishi S (1980) Histopathological study on right endomyocardial biopsy of Kawasaki disease. Br Heart J 43(5):589–592CrossRef Yutani C, Okano K, Kamiya T, Oguchi K, Kozuka T, Ota M, Onishi S (1980) Histopathological study on right endomyocardial biopsy of Kawasaki disease. Br Heart J 43(5):589–592CrossRef
17.
Zurück zum Zitat Frank B, Davidson J, Tong S, Martin B, Heizer H, Anderson MS, Glode MP, Dominguez SR, Jone PN (2016) Myocardial strain and strain rate in Kawasaki disease: range, recovery, and relationship to systemic inflammation/coronary artery dilation. J Clin Exp Cardiol 7(4):432. https://doi.org/10.4172/2155-9880.1000432 CrossRef Frank B, Davidson J, Tong S, Martin B, Heizer H, Anderson MS, Glode MP, Dominguez SR, Jone PN (2016) Myocardial strain and strain rate in Kawasaki disease: range, recovery, and relationship to systemic inflammation/coronary artery dilation. J Clin Exp Cardiol 7(4):432. https://​doi.​org/​10.​4172/​2155-9880.​1000432 CrossRef
21.
Zurück zum Zitat Hsu HB, Fu YC, Tsai SC, Yen RF, Hwang B (2003) Usefulness of Tc-99m HMPAO-labeled WBC heart scan to predict impaired ventricular function and coronary artery dilation in children with Kawasaki disease. Int J Cardiol 92(1):65–69CrossRef Hsu HB, Fu YC, Tsai SC, Yen RF, Hwang B (2003) Usefulness of Tc-99m HMPAO-labeled WBC heart scan to predict impaired ventricular function and coronary artery dilation in children with Kawasaki disease. Int J Cardiol 92(1):65–69CrossRef
22.
Zurück zum Zitat Anderson TM, Meyer RA, Kaplan S (1985) Long-term echocardiographic evaluation of cardiac size and function in patients with Kawasaki disease. Am Heart J 110(1 Pt 1):107–115CrossRef Anderson TM, Meyer RA, Kaplan S (1985) Long-term echocardiographic evaluation of cardiac size and function in patients with Kawasaki disease. Am Heart J 110(1 Pt 1):107–115CrossRef
23.
Zurück zum Zitat Newburger JW, Sanders SP, Burns JC, Parness IA, Beiser AS, Colan SD (1989) Left ventricular contractility and function in Kawasaki syndrome. Effect Intraven Gamma Globul Circ 79(6):1237–1246 Newburger JW, Sanders SP, Burns JC, Parness IA, Beiser AS, Colan SD (1989) Left ventricular contractility and function in Kawasaki syndrome. Effect Intraven Gamma Globul Circ 79(6):1237–1246
24.
Zurück zum Zitat Moran AM, Newburger JW, Sanders SP, Parness IA, Spevak PJ, Burns JC, Colan SD (2000) Abnormal myocardial mechanics in Kawasaki disease: rapid response to gamma-globulin. Am Heart J 139(2 Pt 1):217–223PubMed Moran AM, Newburger JW, Sanders SP, Parness IA, Spevak PJ, Burns JC, Colan SD (2000) Abnormal myocardial mechanics in Kawasaki disease: rapid response to gamma-globulin. Am Heart J 139(2 Pt 1):217–223PubMed
33.
Zurück zum Zitat Sumitomo N, Karasawa K, Taniguchi K, Ichikawa R, Fukuhara J, Abe O, Miyashita M, Kanamaru H, Ayusawa M, Harada K (2008) Association of sinus node dysfunction, atrioventricular node conduction abnormality and ventricular arrhythmia in patients with Kawasaki disease and coronary involvement. Circ J 72(2):274–280CrossRef Sumitomo N, Karasawa K, Taniguchi K, Ichikawa R, Fukuhara J, Abe O, Miyashita M, Kanamaru H, Ayusawa M, Harada K (2008) Association of sinus node dysfunction, atrioventricular node conduction abnormality and ventricular arrhythmia in patients with Kawasaki disease and coronary involvement. Circ J 72(2):274–280CrossRef
34.
Zurück zum Zitat Ichida F, Fatica NS, O'Loughlin JE, Snyder MS, Ehlers KH, Engle MA (1988) Correlation of electrocardiographic and echocardiographic changes in Kawasaki syndrome. Am Heart J 116(3):812–819CrossRef Ichida F, Fatica NS, O'Loughlin JE, Snyder MS, Ehlers KH, Engle MA (1988) Correlation of electrocardiographic and echocardiographic changes in Kawasaki syndrome. Am Heart J 116(3):812–819CrossRef
35.
Zurück zum Zitat Chung KJ, Fulton DR, Lapp R, Spector S, Sahn DJ (1988) One-year follow-up of cardiac and coronary artery disease in infants and children with Kawasaki disease. Am Heart J 115(6):1263–1267CrossRef Chung KJ, Fulton DR, Lapp R, Spector S, Sahn DJ (1988) One-year follow-up of cardiac and coronary artery disease in infants and children with Kawasaki disease. Am Heart J 115(6):1263–1267CrossRef
36.
Zurück zum Zitat Higham PD, Furniss SS, Campbell RW (1995) QT dispersion and components of the QT interval in ischaemia and infarction. Br Heart J 73(1):32–36CrossRef Higham PD, Furniss SS, Campbell RW (1995) QT dispersion and components of the QT interval in ischaemia and infarction. Br Heart J 73(1):32–36CrossRef
37.
Zurück zum Zitat Osada M, Tanaka Y, Komai T, Maeda Y, Kitano M, Komori S, Tamura K, Sugiyama H, Yanai J, Nakazawa S (1999) Coronary arterial involvement and QT dispersion in Kawasaki disease. Am J Cardiol 84(4):466–468CrossRef Osada M, Tanaka Y, Komai T, Maeda Y, Kitano M, Komori S, Tamura K, Sugiyama H, Yanai J, Nakazawa S (1999) Coronary arterial involvement and QT dispersion in Kawasaki disease. Am J Cardiol 84(4):466–468CrossRef
43.
Zurück zum Zitat Phillips M, Robinowitz M, Higgins JR, Boran KJ, Reed T, Virmani R (1986) Sudden cardiac death in Air Force recruits. A 20-year review. JAMA 256(19):2696–2699CrossRef Phillips M, Robinowitz M, Higgins JR, Boran KJ, Reed T, Virmani R (1986) Sudden cardiac death in Air Force recruits. A 20-year review. JAMA 256(19):2696–2699CrossRef
45.
Zurück zum Zitat Maron BJ, Udelson JE, Bonow RO, Nishimura RA, Ackerman MJ, Estes NA 3rd, Cooper LT Jr., Link MS, Maron MS, American Heart Association E, Arrhythmias Committee of Council on Clinical Cardiology CoCDiYCoC, Stroke Nursing CoFG, Translational B, American College of C (2015) Eligibility and disqualification recommendations for competitive athletes with cardiovascular abnormalities: task force 3: hypertrophic cardiomyopathy, arrhythmogenic right ventricular cardiomyopathy and other cardiomyopathies, and myocarditis: a scientific statement from the American Heart Association and American College of Cardiology. Circulation 132(22):e273–280. https://doi.org/10.1161/CIR.0000000000000239 CrossRefPubMed Maron BJ, Udelson JE, Bonow RO, Nishimura RA, Ackerman MJ, Estes NA 3rd, Cooper LT Jr., Link MS, Maron MS, American Heart Association E, Arrhythmias Committee of Council on Clinical Cardiology CoCDiYCoC, Stroke Nursing CoFG, Translational B, American College of C (2015) Eligibility and disqualification recommendations for competitive athletes with cardiovascular abnormalities: task force 3: hypertrophic cardiomyopathy, arrhythmogenic right ventricular cardiomyopathy and other cardiomyopathies, and myocarditis: a scientific statement from the American Heart Association and American College of Cardiology. Circulation 132(22):e273–280. https://​doi.​org/​10.​1161/​CIR.​0000000000000239​ CrossRefPubMed
Metadaten
Titel
Echocardiographic Parameters During and Beyond Onset of Kawasaki Disease Correlate with Onset Serum N-Terminal pro-Brain Natriuretic Peptide (NT-proBNP)
verfasst von
Laurent Desjardins
Audrey Dionne
Léamarie Meloche-Dumas
Anne Fournier
Nagib Dahdah
Publikationsdatum
14.03.2020
Verlag
Springer US
Erschienen in
Pediatric Cardiology / Ausgabe 5/2020
Print ISSN: 0172-0643
Elektronische ISSN: 1432-1971
DOI
https://doi.org/10.1007/s00246-020-02340-z

Weitere Artikel der Ausgabe 5/2020

Pediatric Cardiology 5/2020 Zur Ausgabe

Update Kardiologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.